Malignant mesothelioma metastatic to the oral region and latest topics (Review)
- Authors:
- Yuichi Ohnishi
- Tomoko Fujii
- Tsukasa Sakamoto
- Masahiro Watanabe
- Tomokazu Motohashi
- Hirohito Kubo
- Masahiro Nakajima
-
Affiliations: Second Department of Oral and Maxillofacial Surgery, Osaka Dental University, Chuo‑ku, Osaka 540‑0008, Japan - Published online on: September 7, 2020 https://doi.org/10.3892/mco.2020.2131
- Article Number: 61
This article is mentioned in:
Abstract
Boutin C, Schlesser M, Frenay C and Astoul P: Malignant pleural mesothelioma. Eur Respir J. 12:972–981. 1988.PubMed/NCBI View Article : Google Scholar | |
Sugarbaker DJ and Norberto JJ: Multimodality management of malignant pleural mesothelioma. Chest. 113 (Suppl 1):S61–S65. 1988.PubMed/NCBI View Article : Google Scholar | |
Wagner JC, Sleggs CA and Marchand P: Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med. 17:260–271. 1960.PubMed/NCBI View Article : Google Scholar | |
Hanna L and Macbeth F: Mesothelioma. In: Practical Clinical Oncology. Hanna L, Crosby T and Macbeth F (eds). 1st edition. Cambridge University Press: Cambridge, New York, pp328-333, 978-0-521-61816-8, 2008. | |
Galateau-Salle F, Brambilla E and Cagle PT: Clinical aspects of mesothelioma. In: Pathology of Malignant Mesothelioma. Galateau-Salle F (ed). Springer, London, pp31-39, 978-1-84628-012-2, 2006. | |
Law MR, Hodson ME and Heard BE: Malignant mesothelioma of the pleura: Relation between histological type and clinical behaviour. Thorax. 37:810–815. 1982.PubMed/NCBI View Article : Google Scholar | |
Hesterberg TW and Barrett JC: Induction by asbestos fibers of anaphase abnormalities: Mechanism for aneuploidy induction and possibly carcinogenesis. Carcinogenesis. 6:473–475. 1985.PubMed/NCBI View Article : Google Scholar | |
Cheng JQ, Lee WC, Klein MA, Cheng GZ, Jhanwar SC and Testa JR: Frequent mutations of NF2 and allelic loss from chromosome band 22q12 in malignant mesothelioma: Evidence for a two-hit mechanism of NF2 inactivation. Genes Chromosomes Cancer. 24:238–242. 1999.PubMed/NCBI | |
Cote RJ, Jhanwar SC, Novick S and Pellicer A: Genetic alterations of the p53 gene are a feature of malignant mesotheliomas. Cancer Res. 51:5410–5416. 1991.PubMed/NCBI | |
Zucali PA, Ceresoli GL, De Vincenzo F, Simonelli M, Lorenzi E, Gianoncelli L and Santoro A: Advances in the biology of malignant pleural mesothelioma. Cancer Treat Rev. 37:543–58. 2011.PubMed/NCBI View Article : Google Scholar | |
Papp T, Schipper H, Pemsel H, Bastrop R, Muller KM, Wiethege T, Weiss DG, Dopp E, Schiffmann D and Rahman Q: Mutational analysis of N-ras, p53, p16INK4a, p14ARF and CDK4 genes in primary human malignant mesotheliomas. Int J Oncol. 18:425–433. 2001.PubMed/NCBI View Article : Google Scholar | |
Yang H, Bocchetta M, Kroczynska B, Elmishad AG, Chen Y, Liu Z, Bubici C, Mossman BT, Pass HI, Testa JR, et al: TNF-alpha inhibits asbestos induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis. Proc Natl Acad Sci USA. 103:10397–10402. 2006.PubMed/NCBI View Article : Google Scholar | |
Cicala C, Pompetti F and Carbone M: SV40 induces mesotheliomas in hamsters. Am J Pathol. 142:1524–1534. 1993.PubMed/NCBI | |
Jasani BI and Gibbs A: Mesothelioma not associated with asbestos exposure. Arch Pathol Lab Med. 136:262–7. 2012.PubMed/NCBI View Article : Google Scholar | |
Cavazza A, Travis LB, Travis WD, Wolfe JT III, Foo ML, Gillespie DJ, Weidner N and Colby TV: Post-irradiation malignant mesothelioma. Cancer. 77:1379–1385. 1996.PubMed/NCBI View Article : Google Scholar | |
Carbone M, Ly BH, Dodson RF, Pagano I, Morris PT, Dogan UA, Gazdar AF, Pass HI and Yang H: Malignant mesothelioma: Facts, myths, and hypotheses. J Cell Physiol. 227:44–58. 2012.PubMed/NCBI View Article : Google Scholar | |
Bueno R, Stawiski EW, Goldstein LD, Durinck S, De Rienzo A, Modrusan Z, Gnad F, Nguyen TT, Jaiswal BS, Chirieac LR, et al: Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations. Nat Genet. 48:407–416. 2016.PubMed/NCBI View Article : Google Scholar | |
Goldberg M, Imbernon E, Rolland P, Gilg Soit Ilg A, Savès M, de Quillacq A, Frenay C, Chamming's S, Arveux P, Boutin C, et al: The French National Mesothelioma Surveillance Program. Occup Environ Med. 63:390–395. 2006.PubMed/NCBI View Article : Google Scholar | |
Carbone M, Shimizu D, Napolitano A, Tanji M, Pass H, Yang H and Pastorino S: Positive nuclear BAP1 immunostaining helps differentiate nonsmall cell lung carcinomas from malignant mesothelioma. Oncotarget. 7:59314–59321. 2016.PubMed/NCBI View Article : Google Scholar | |
Guo Z, Carbone M, Zhang X, Su D, Sun W, Lou J, Gao Z, Shao D, Chen J, Zhang G, et al: Improving the Accuracy of Mesothelioma Diagnosis in China. J Thorac Oncol. 12:714–723. 2017.PubMed/NCBI View Article : Google Scholar | |
King JE, Thatcher N, Pickering CAC and Hasleton PS: Sensitivity and specificity of immunohistochemical markers used in the diagnosis of epithelioid mesothelioma: A detailed systematic analysis using published data. Histopathology. 48:223–232. 2006.PubMed/NCBI View Article : Google Scholar | |
Kato Y, Tsuta K, Seki K, Maeshima AM, Watanabe S, Suzuki K, Asamura H, Tsuchiya R and Matsuno Y: Immunohistochemical detection of GLUT1 can discriminate between reactive mesothelium and malignant mesothelioma. Mod Pathol. 20:215–220. 2007.PubMed/NCBI View Article : Google Scholar | |
Brenner J, Sordillo PP, Magill GB and Golbey RB: Malignant mesothelioma of the pleura: review of 123 patients. Cancer. 49:2431–2435. 1982.PubMed/NCBI View Article : Google Scholar | |
Husain AN, Colby TV, Ordóñez NG, Krausz T, Borczuk A, Cagle PT, Chirieac LR, Churg A, Galateau-Salle F, Gibbs AR, et al: Guidelines for pathologic diagnosis of malignant mesothelioma: A consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. 133:1317–1331. 2009.PubMed/NCBI View Article : Google Scholar | |
Galateau-Salle F, Brambilla E and Cagle PT: Classification and histologic features of epithelioid mesotheliomas. In: Pathology of Malignant Mesothelioma. Galateau-Salle F (ed). Springer, London, pp68-131, 978-1-84628-012-2, 2006. | |
Doglioni C, Dei Tos AP, Laurino L, Iuzzolino P, Chiarelli C, Celio MR and Viale G: Calretenin: A novel immunocytochemical marker for mesothelioma. Am J Surg Pathol. 20:1037–1046. 1996.PubMed/NCBI View Article : Google Scholar | |
Marchevsky AM: Application of immunohistochemistry to the diagnosis of malignant mesothelioma. Arch Pathol Lab Med. 132:397–401. 2008.PubMed/NCBI View Article : Google Scholar | |
Pass HI and Carbone M: Current status of screening for malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg. 21:97–104. 2009.PubMed/NCBI View Article : Google Scholar | |
Ray M and Kindler HL: Malignant pleural mesothelioma: an update on biomarkers and treatment. Chest. 136:888–896. 2009.PubMed/NCBI View Article : Google Scholar | |
Kerpel SM and Freedman PD: Metastatic mesothelioma of the oral cavity. Oral Surg Oral Med Oral Pathol. 76:746–751. 1993.PubMed/NCBI View Article : Google Scholar | |
Sproat CP, Brown AE and Lindley RP: Oral metastasis in malignant pleural mesothelioma. Br J Oral Maxillofac Surg. 31:316–317. 1993.PubMed/NCBI View Article : Google Scholar | |
Piattelli A, Fioroni M and Rubini C: Tongue metastasis from a malignant diffuse mesothelioma of the pleura: Report of a case. J Oral Maxillofac Surg. 57:861–863. 1999.PubMed/NCBI View Article : Google Scholar | |
Garcia-Reija MF, Matilla JM, De Paz A, Sanchez-Cuellar A and Verrier A: Unusual metastasis to the mandibular alveolus of malignant pleural mesothelioma. Otolaryngol Head Neck Surg. 126:435–437. 2002.PubMed/NCBI View Article : Google Scholar | |
Cassarino DS, Xue W and Shannon KJ: Widespread cutaneous and perioral metastases of mesothelioma. J Cutan Pathol. 30:582–585. 2003.PubMed/NCBI View Article : Google Scholar | |
Zanconati F, Delconte A, Bonifacio-Gori D and Falconieri G: Metastatic pleural mesothelioma presenting with solitary involvement of the tongue: Report of a new case and review of the literature. Int J Surg Pathol. 11:51–55. 2003.PubMed/NCBI View Article : Google Scholar | |
Soyuer I, Soyuer S, Canöz Ö, Coşkun S and Balkanli S, kun S and Balkanli S: Three patients with unusual metastases. Cytopathology. 15:58–62. 2004. | |
Terakado N, Shintani S, Nakashiro K and Hamakawa H: Malignant pleural mesothelioma metastasis to the mandible. Int J Oral Maxillofac Surg. 33:789–800. 2004.PubMed/NCBI View Article : Google Scholar | |
Tho LM and O'Rouke NP: Unusual metastases from malignant pleural mesothelioma. Clin Oncol (R Coll Radiol). 17(293)2005.PubMed/NCBI View Article : Google Scholar | |
Higginson DS, Brahmer J, Tufano RP and Bajaj GK: Pleural mesothelioma metastatic to the tongue. J Clin Oncol. 25:2133–2135. 2007.PubMed/NCBI View Article : Google Scholar | |
Hashitani S, Sakurai K, Takaoka K and Urade M: Metastatic malignant pleural mesothelioma of the tongue: Report of a case. Brit J Oral Maxillofac Surg. 47(247)2009.PubMed/NCBI View Article : Google Scholar | |
Kirke D, Horwood K and Wallwork B: Floor of mouth and tongue metastasis from malignant pleural mesothelioma. ANZ J Surg. 80:556–558. 2010.PubMed/NCBI View Article : Google Scholar | |
Murray LJ, Higham J, Suvarna SK, Craig GT, Bridgewater CH, Fisher PM and Thornhill MH: Oral presentation of malignant mesothelioma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 111:e21–e26. 2011.PubMed/NCBI View Article : Google Scholar | |
Sinon SH, Rich AM, Hussaini HM, Yoon HS, Firth NA and Seymour GJ: Metastases to the oral region from pleural mesothelioma: Clinicopathologic review. Head Neck. 35:599–604. 2013.PubMed/NCBI View Article : Google Scholar | |
Billè A, Platania M, Pelosi G, Padovano B, Quattrone P and Pastorino U: Gingival metastasis as first sign of multiorgan dissemination of epithelioid malignant mesothelioma. J Thorac Oncol. 9:1226–1229. 2014.PubMed/NCBI View Article : Google Scholar | |
Arslan A, Ozcakir-Tomruk C, Deniz E and Akin O: A case report of metastasis of malignant mesothelioma to the retromolar trigone. World J Surg Oncol. 14(188)2016.PubMed/NCBI View Article : Google Scholar | |
Ohnishi Y, Sugitatsu M, Watanabe M, Fujii T and Kakudo K: Metastasis of mesothelioma to the maxillary gingiva. Oncol Lett. 8:1214–1216. 2014.PubMed/NCBI View Article : Google Scholar | |
Moser S, Beer M, Damerau G, Lubbers HT, Gratz KW and Kruse AL: A case report of metastasis of malignant mesothelioma to the oral gingiva. Head Neck Oncol. 3(21)2011.PubMed/NCBI View Article : Google Scholar | |
Sawaki K, Okazaki F, Sato A, Najano M, Takagi S and Iida S: A case of malignant pleural mesothelioma with metastasis to the upper jaw. Japanese J Oral Maxillofac Surg. 61:168–172. 2015. | |
Vazquez MV, Selvendran S, Cheluvappa R and McKay MJ: Peritoneal mesothelioma metastasis to the tongue-comparison with 8 pleural mesothelioma reports with tongue metastasis. Ann Med Surg (Lond). 5:101–105. 2016. | |
Tanaka T, Nakamatsu K and Imamura T: Metastasis of malignant pleural mesothelioma to maxillary gingiva: A case report and literature review. J Oral Maxillofac Surg Med Pathol. 32:140–144. 2020. | |
Spirtas R, Heineman EF, Bernstein L, Beebe GW, Keehn RJ, Stark A, Harlow BL and Benichou J: Malignant mesothelioma: attributable risk of asbestos exposure. Occup Environ Med. 51:804–811. 1994.PubMed/NCBI View Article : Google Scholar | |
Baumann F, Ambrosi JP and Carbone M: Asbestos is not just asbestos: An unrecognised health hazard. Lancet Oncol. 14:576–578. 2013.PubMed/NCBI View Article : Google Scholar | |
Carbone M, Baris YI, Bertino P, Brass B, Comertpay S, Dogan AU, Gaudino G, Jube S, Kanodia S, Partridge CR, et al: Erionite exposure in North Dakota and Turkish villages with mesothelioma. Proc Natl Acad Sci USA. 108:13618–13623. 2011.PubMed/NCBI View Article : Google Scholar | |
Hillegass JM, Shukla A, Lathrop SA, MacPherson MB, Beuschel SL, Butnor KJ, Testa JR, Pass HI, Carbone M, Steele C and Mossman BT: Inflammation precedes the development of human malignant mesotheliomas in a SCID mouse xenograft model. Ann N Y Acad Sci. 1203:7–14. 2010.PubMed/NCBI View Article : Google Scholar | |
Yang H, Rivera Z, Jube S, Nasu M, Bertino P, Goparaju C, Franzoso G, Lotze MT, Krausz T, Pass HI, et al: Programmed necrosis induced by asbestos in human mesothelial cells causes high mobility group box 1 protein release and resultant inflammation. Proc Natl Acad Sci USA. 107:12611–12616. 2010.PubMed/NCBI View Article : Google Scholar | |
Carbone M and Yang H: Molecular pathways: Targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma. Clin Cancer Res. 18:598–604. 2012.PubMed/NCBI View Article : Google Scholar | |
Napolitano A, Antoine DJ, Pellegrini L, Baumann F, Pagano I, Pastorino S, Goparaju CM, Prokrym K, Canino C, Pass HI, et al: HMGB1 and its hyperacetylated isoform are sensitive and specific serum biomarkers to detect asbestos exposure and to identify mesothelioma patients. Clin Cancer Res. 22:3087–3096. 2016.PubMed/NCBI View Article : Google Scholar | |
Carbone M, Emri S, Dogan AU, Steele I, Tuncer M, Pass HI and Baris YI: A mesothelioma epidemic in Cappadocia: Scientific developments and unexpected social outcomes. Nat Rev Cancer. 7:147–154. 2007.PubMed/NCBI View Article : Google Scholar | |
Dogan AU, Baris YI, Dogan M, Emri S, Steele I, Elmishad AG and Carbone M: Genetic predisposition to fiber carcinogenesis causes a mesothelioma epidemic in Turkey. Cancer Res. 66:5063–5068. 2006.PubMed/NCBI View Article : Google Scholar | |
Testa JR, Cheung M, Pei J, Krausz T, Testa JR and Gaudino G: Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet. 43:1022–1025. 2011.PubMed/NCBI View Article : Google Scholar | |
Carbone M, Yang H, Pass HI, Krausz T, Testa JR and Gaudino G: BAP1 and cancer. Nat Rev Cancer. 13:153–159. 2013.PubMed/NCBI View Article : Google Scholar | |
Nasu M, Emi M, Pastorino S, Tanji M, Powers A, Luk H, Baumann F, Zhang YA, Gazdar A, Kanodia S, et al: High Incidence of Somatic BAP1 Alterations in Sporadic Malignant Mesothelioma. J Thorac Oncol. 10:565–576. 2015.PubMed/NCBI View Article : Google Scholar | |
Mori T, Sumii M, Fujishima F, Ueno K, Emi M, Nagasaki M, Ishioka C and Chiba N: Somatic alteration and depleted nuclear expression of BAP1 in human esophageal squamous cell carcinoma. Cancer Sci. 106:1118–1129. 2015.PubMed/NCBI View Article : Google Scholar | |
Yoshikawa Y, Emi M, Hashimoto-Tamaoki T, Ohmuraya M, Sato A, Tsujimura T, Hasegawa S, Nakano T, Nasu M, Pastorino S, et al: High density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma. Proc Natl Acad Sci USA. 113:13432–13437. 2016.PubMed/NCBI View Article : Google Scholar | |
Cutrone R, Lednicky J, Dunn G, Rizzo P, Bocchetta M, Chumakov K, Minor P and Carbone M: Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961. Cancer Res. 65:10273–10279. 2005.PubMed/NCBI View Article : Google Scholar | |
Qi F, Carbone M, Yang H and Gaudino G: Simian virus 40 transformation, malignant mesothelioma and brain tumors. Expert Rev Respir Med. 5:683–697. 2011.PubMed/NCBI View Article : Google Scholar | |
Bocchetta M, Eliasz S, De Marco MA, Rudzinski J, Zhang L and Carbone M: The SV40 large T antigen-p53 complexes bind and activate the insulin-like growth factor-I promoter stimulating cell growth. Cancer Res. 68:1022–1029. 2008.PubMed/NCBI View Article : Google Scholar | |
Banaei A, Auvert B, Goldberg M, Gueguen A, Luce D and Goldberg S: Future trends in mortality of French men from mesothelioma. Occup Environ Med. 57:488–494. 2000.PubMed/NCBI View Article : Google Scholar | |
Leigh J, Davidson P, Hendrie L and Berry D: Malignant mesothelioma in Australia, 1945-2000. Am J Ind Med. 41:188–201. 2002.PubMed/NCBI View Article : Google Scholar | |
Price B: Analysis of current trends in United States mesothelioma incidence. Am J Epidemiol. 145:211–218. 1997.PubMed/NCBI View Article : Google Scholar | |
Robinson BW and Lake RA: Advances in malignant mesothelioma. N Engl J Med. 353:1591–1603. 2005.PubMed/NCBI View Article : Google Scholar |